Exploring Apixaban for Anticoagulation in Severe COVID-19
In a recent publication Wenzler et al conducted a single-center, retrospective cohort study that included 21 patients in an intensive-care unit with severe COVID-19 infections treated with apixaban for atrial fibrillation, venous thromboembolism, catheter-induced thrombosis, and/or COVID-19–induced coagulopathy. The primary objective was to assess the prevalence of bleeding events, and secondary objectives included thromboembolic events, coagulation parameters, and mortality. Read more.

Study Finds Statin Therapy Benefits After Revascularization in Peripheral Arterial Occlusive Disease
According to a study in the Journal of the American Heart Association, statin therapy initiation after index revascularization in patients with peripheral arterial occlusive disease (PAOD) was correlated with considerable declines in mortality, cardiovascular events, and diminished risk for amputation in patients with chronic limb-threatening ischemia. This study was the first to assess statin therapy in symptomatic patients with PAOD after revascularization. Read more.

Cannabis Use Correlates With Higher Recurrent Acute MI Rates
Cannabis users were found to have elevated rates of acute myocardial infarction (AMI) and recurrent AMI compared with nonusers, according to two presentations at the American Heart Association (AHA) Scientific Sessions 2020, held virtually in November 2020. These studies explored the incidence of cannabis use among those patients who presented with AMI in addition to their outcomes after percutaneous coronary intervention. Read more.